サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420152

欧州の放射性トレーサー市場の2030年予測-地域別分析：トレーサータイプ、検査タイプ、用途、エンドユーザー別

Europe Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 128 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
欧州の放射性トレーサー市場の2030年予測-地域別分析：トレーサータイプ、検査タイプ、用途、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 128 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の放射性トレーサー市場は、2022年に41億7,525万米ドルと評価され、2030年には160億9,893万米ドルに達すると予測され、2022年から2030年までのCAGRは18.4%で成長すると予測されています。

がん診断における放射性トレーサーの使用が欧州の放射性トレーサー市場を活性化

がん患者は世界的に増加しており、ヘルスケア分野における腫瘍学は著しく発展している分野です。Institute for Health Metrics and Evaluation（IHME）によると、がんは心血管障害に次ぐ2番目の主要な死因です。がんの診断と治療における先端材料と薬剤の使用は、腫瘍学の顕著な発展とともに急増しています。放射性トレーサーを用いた画像診断は、前立腺がん、婦人科がん、血液を介するがんなど、がんの種類を正確に診断するために用いられる高度な診断法のひとつです。体内に注入された放射性トレーサーは、がん特有の部位に付着し、がんの種類を正確に診断します。トレーサーはまた、がんの発生段階を判断するのに役立ち、ほとんどの場合、効果的な治療とより早い回復を可能にします。PETとSPECTは、腫瘍の検出にガンマ線放出核種を使用する核画像診断法の一つです。腫瘍が成長するにつれて、PETやSPECTの結合体への取り込みが時間とともに増加し、核画像薬剤の存在によりコントラストが向上します。これにより血液クリアランスが促進され、鮮明な診断画像が得られるようになります。がんの検出に最もよく使われる放射性トレーサーはF-18フルオロデオキシグルコース（18F-FDG）で、ブドウ糖や砂糖に似た化合物です。がん細胞は非常に活発で、正常細胞よりも多くのエネルギー、すなわち余分なブドウ糖を必要とします。PETやSPECTなどの画像診断装置は、FDGが放出するこのエネルギーを検出し、体内の放射性トレーサーの位置を示す画像を作成します。これにより、患者の体内のがん細胞の位置を特定し、がんの種類や病期に応じて治療を調整することができます。このように、がん診断における放射性トレーサーの使用の増加は、推定期間中の市場拡大を促進すると予想されます。

欧州の放射性トレーサー市場概要

欧州の放射性トレーサー市場は、ドイツ、フランス、イタリア、英国、スペイン、その他欧州に細分化されます。この地域の市場成長は、アルツハイマー病などの神経疾患の有病率の上昇や、この地域で事業を展開する企業による新興国市場の開拓などに関連しています。

欧州の放射性トレーサー市場の収益と2030年までの予測（金額）

欧州の放射性トレーサー市場のセグメンテーション

欧州の放射性トレーサー市場は、トレーサータイプ、検査タイプ、エンドユーザー、用途、国によって区分されます。トレーサータイプに基づき、欧州の放射性トレーサー市場はテクネチウム-99m &Tc-97m、ヨウ素131、鉄-59、ルテチウム-171、塩化ルビジウム（Rb-82） &アンモニア（N-13）、スカンジウム-46、シーボルギウム-269、ハッシウム-269に区分される、クエン酸ガリウムGa 67、前立腺特異的膜抗原（PSMA）（Ga-68）、FDDNP（F-18）＆FDOPA（F-18）、リン-32＆クロム-51、タリウム-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE（Ga-68）、その他。その他セグメントが2022年に最大の市場シェアを占めました。

検査タイプ別に見ると、欧州の放射性トレーサー市場はPET、SPECT、その他に区分されます。SPECTセグメントが2022年に最大の市場シェアを占めました。

エンドユーザー別では、欧州放射性トレーサー市場は病院＆クリニック、診断センター、学術＆研究機関、その他に区分されます。病院＆クリニックセグメントが2022年に最大の市場シェアを占めました。

用途別では、欧州の放射性トレーサー市場は、腫瘍学、肺、神経学、心臓学、その他に区分されます。2022年には腫瘍分野が最大の市場シェアを占めました。

国別では、欧州放射性トレーサー市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2022年の欧州放射性トレーサー市場シェアはドイツが独占。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、Newcastle University、ABX advanced biochemical compounds GmbH、Novartis AG、Curium、Blue Earth Diagnostics Limited、General Electric Co、IBA Radiopharma Solutionsは、欧州放射性トレーサー市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州放射性トレーサー市場- 主要産業力学

  • 主な市場促進要因
    • 慢性疾患の有病率の上昇
    • 核イメージング技術の利用の増加
  • 市場抑制要因
    • 放射性トレーサーの短い使用期限
    • 核医学画像診断手順の代替品の入手可能性
  • 市場機会
    • 放射性トレーサー研究開発への新たな取り組み
  • 今後の動向
    • がん診断における放射性トレーサーの使用
  • 影響分析

第5章 放射性トレーサー市場：欧州市場分析

  • 放射性トレーサー市場の収益、2022年～2030年

第6章 欧州の放射性トレーサー市場-収益と2030年までの予測：トレーサータイプ別

  • トレーサー概要
  • 放射性トレーサー市場：2022年・2030年収益シェア（%）トレーサータイプ別
  • テクネチウム99mおよびTC-97m
  • ヨウ素131
  • 鉄59
  • ルテチウム171
  • RB82およびアンモニアN-13
  • スカンジウム46
  • シーボーギウム-269
  • ハッシウム-269
  • クエン酸ガリウムGA67
  • PSMA GA68
  • FDDNP（F-18）およびFDOPA（f-18）
  • リン32およびクロム-51
  • タリウム-201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE GA 68
  • その他

第7章 欧州の放射性トレーサー市場-収益と2030年までの予測：検査タイプ別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）検査タイプ別
  • PET
  • SPECT
  • その他

第8章 欧州の放射性トレーサー市場-収益と2030年までの予測：用途別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）用途別
  • 腫瘍
  • 肺
  • 神経
  • 循環器
  • その他

第9章 欧州の放射性トレーサー市場-収益と2030年までの予測：エンドユーザー別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）エンドユーザー別
  • 病院および診療所
  • 診断センター
  • 学術・研究機関
  • その他

第10章 欧州の放射性トレーサー市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第11章 放射性トレーサー市場の業界情勢

  • 有機的開発
  • 無機的開発

第12章 放射性トレーサー市場：主要企業プロファイル

  • Rotem Industries Ltd
  • ABX advanced biochemical compounds GmbH
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • Blue Earth Diagnostics Limited
  • General Electric Co
  • IBA Radiopharma Solutions

第13章 付録

図表

List Of Tables

  • Table 1. Europe Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 16. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 17. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 19. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 20. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 21. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 22. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 23. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 24. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 25. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 26. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Europe Radioactive Tracer Market

List Of Figures

  • Figure 1. Europe Radioactive Tracer Market Segmentation, By Country
  • Figure 2. Europe Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Europe Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: Europe Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Europe Radioactive Tracer Market, By Country, 2022 ($Mn)
  • Figure 41. Europe Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. Germany Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. UK Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. France Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Italy Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Spain Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Europe Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029114

The Europe radioactive tracer market was valued at US$ 4,175.25 million in 2022 and is expected to reach US$ 16,098.93 million by 2030; it is estimated to grow at a CAGR of 18.4% from 2022 to 2030.

Use of Radioactive Tracer in Cancer Diagnosis fuel the Europe Radioactive Tracer Market

Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient's body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.

Europe Radioactive Tracer Market Overview

The Europe radioactive tracer market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with such as rising prevalence of neurologic disorders such as, Alzheimer's and others along with the developments made by the players operating in the region.

Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Europe Radioactive Tracer Market Segmentation

The Europe radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Europe radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Europe radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Europe radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Europe radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Europe radioactive tracer market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, ABX advanced biochemical compounds GmbH, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading companies operating in the Europe radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 New Initiatives for Radioactive Tracer R&D
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - Europe Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. Europe Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Radioactive Tracer Market - Country Analysis

  • 10.1 Europe Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Europe Radioactive Tracer Market by Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Germany Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Germany Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 Germany Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 Germany Radioactive Tracer Market, by Application
        • 10.1.2.1.6 Germany Radioactive Tracer Market, by End-User
      • 10.1.2.2 UK
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 UK Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 UK Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 UK Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 UK Radioactive Tracer Market, by Application
        • 10.1.2.2.6 UK Radioactive Tracer Market, by End-User
      • 10.1.2.3 France
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 France Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 France Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 France Radioactive Tracer Market, by Application
        • 10.1.2.3.6 France Radioactive Tracer Market, by End-User
      • 10.1.2.4 Italy
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.3 Italy Radioactive Tracer Market, by Tracer Types
        • 10.1.2.4.4 Italy Radioactive Tracer Market, by Test Type
        • 10.1.2.4.5 Italy Radioactive Tracer Market, by Application
        • 10.1.2.4.6 Italy Radioactive Tracer Market, by End-User
      • 10.1.2.5 Spain
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 Spain Radioactive Tracer Market, by Tracer Types
        • 10.1.2.5.4 Spain Radioactive Tracer Market, by Test Type
        • 10.1.2.5.5 Spain Radioactive Tracer Market, by Application
        • 10.1.2.5.6 Spain Radioactive Tracer Market, by End-User
      • 10.1.2.6 Rest of Europe
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Europe Radioactive Tracer Market, by Tracer Types
        • 10.1.2.6.4 Rest of Europe Radioactive Tracer Market, by Test Type
        • 10.1.2.6.5 Rest of Europe Radioactive Tracer Market, by Application
        • 10.1.2.6.6 Rest of Europe Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 ABX advanced biochemical compounds GmbH
    • 12.2.1 Business Description
    • 12.2.2 Products and Services
    • 12.2.3 Financial Overview
    • 12.2.4 SWOT Analysis
    • 12.2.5 Key Developments
  • 12.3 Invicro LLC
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Cardinal Health Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Newcastle University
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Novartis AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Curium
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Blue Earth Diagnostics Limited
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 General Electric Co
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 IBA Radiopharma Solutions
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms